CCCC
Price
$3.76
Change
+$0.02 (+0.53%)
Updated
Sep 4 closing price
Capitalization
462.57M
52 days until earnings call
Intraday BUY SELL Signals
GLUE
Price
$13.84
Change
-$0.54 (-3.76%)
Updated
Sep 4 closing price
Capitalization
1.18B
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs GLUE

CCCC vs GLUE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CCCC vs. GLUE commentary
Sep 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and GLUE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2026
Stock price -- (CCCC: $3.76 vs. GLUE: $13.84)
Brand notoriety: CCCC and GLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 98% vs. GLUE: 59%
Market capitalization -- CCCC: $462.57M vs. GLUE: $1.18B
CCCC [@Biotechnology] is valued at $462.57M. GLUE’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileGLUE’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • GLUE’s FA Score: 1 green, 4 red.
According to our system of comparison, both CCCC and GLUE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while GLUE’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 6 bearish.
  • GLUE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -2.34% price change this week, while GLUE (@Biotechnology) price change was +3.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 29, 2026.

GLUE is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($1.18B) has a higher market cap than CCCC($463M). CCCC YTD gains are higher at: 96.859 vs. GLUE (-11.735). CCCC has higher annual earnings (EBITDA): -99.45M vs. GLUE (-173.73M). GLUE has more cash in the bank: 621M vs. CCCC (254M). GLUE has less debt than CCCC: GLUE (38M) vs CCCC (56.9M). CCCC has higher revenues than GLUE: CCCC (35M) vs GLUE (28.7M).
CCCCGLUECCCC / GLUE
Capitalization463M1.18B39%
EBITDA-99.45M-173.73M57%
Gain YTD96.859-11.735-825%
P/E RatioN/A49.25-
Revenue35M28.7M122%
Total Cash254M621M41%
Total Debt56.9M38M150%
FUNDAMENTALS RATINGS
CCCC: Fundamental Ratings
CCCC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCGLUE
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
GLUE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTGRX87.331.41
+1.64%
BNY Mellon Technology Growth A
PVIVX56.530.71
+1.27%
Paradigm Micro-Cap
FSFJX45.860.16
+0.35%
Fidelity Advisor Focused Stock M
AFIFX103.61-0.02
-0.02%
American Funds Fundamental Invs F-1
CCASX65.57-0.09
-0.14%
Conestoga Small Cap Investors